IBDEI06J ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,2861,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2861,1,3,0)
 ;;=3^SCREEN-MYCOTIC INFECT
 ;;^UTILITY(U,$J,358.3,2861,1,4,0)
 ;;=4^V75.4
 ;;^UTILITY(U,$J,358.3,2861,2)
 ;;=^295645
 ;;^UTILITY(U,$J,358.3,2862,0)
 ;;=V75.5^^28^249^56
 ;;^UTILITY(U,$J,358.3,2862,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2862,1,3,0)
 ;;=3^SCREEN-SCHISTOSOMIASIS
 ;;^UTILITY(U,$J,358.3,2862,1,4,0)
 ;;=4^V75.5
 ;;^UTILITY(U,$J,358.3,2862,2)
 ;;=^295646
 ;;^UTILITY(U,$J,358.3,2863,0)
 ;;=V75.6^^28^249^22
 ;;^UTILITY(U,$J,358.3,2863,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2863,1,3,0)
 ;;=3^SCREEN-FILARIASIS
 ;;^UTILITY(U,$J,358.3,2863,1,4,0)
 ;;=4^V75.6
 ;;^UTILITY(U,$J,358.3,2863,2)
 ;;=^295647
 ;;^UTILITY(U,$J,358.3,2864,0)
 ;;=V75.7^^28^249^29
 ;;^UTILITY(U,$J,358.3,2864,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2864,1,3,0)
 ;;=3^SCREEN-HELMINTHIASIS
 ;;^UTILITY(U,$J,358.3,2864,1,4,0)
 ;;=4^V75.7
 ;;^UTILITY(U,$J,358.3,2864,2)
 ;;=^295648
 ;;^UTILITY(U,$J,358.3,2865,0)
 ;;=V75.8^^28^249^48
 ;;^UTILITY(U,$J,358.3,2865,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2865,1,3,0)
 ;;=3^SCREEN-PARASITIC DIS NEC
 ;;^UTILITY(U,$J,358.3,2865,1,4,0)
 ;;=4^V75.8
 ;;^UTILITY(U,$J,358.3,2865,2)
 ;;=^295649
 ;;^UTILITY(U,$J,358.3,2866,0)
 ;;=V76.0^^28^249^77
 ;;^UTILITY(U,$J,358.3,2866,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2866,1,3,0)
 ;;=3^SCRN MAL NEOP RESP ORG
 ;;^UTILITY(U,$J,358.3,2866,1,4,0)
 ;;=4^V76.0
 ;;^UTILITY(U,$J,358.3,2866,2)
 ;;=^295651
 ;;^UTILITY(U,$J,358.3,2867,0)
 ;;=V76.10^^28^249^66
 ;;^UTILITY(U,$J,358.3,2867,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2867,1,3,0)
 ;;=3^SCRN MAL NEOP BREAST
 ;;^UTILITY(U,$J,358.3,2867,1,4,0)
 ;;=4^V76.10
 ;;^UTILITY(U,$J,358.3,2867,2)
 ;;=^317968
 ;;^UTILITY(U,$J,358.3,2868,0)
 ;;=V76.11^^28^249^71
 ;;^UTILITY(U,$J,358.3,2868,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2868,1,3,0)
 ;;=3^SCRN MAL NEOP MAMMO HIGH RISK PT
 ;;^UTILITY(U,$J,358.3,2868,1,4,0)
 ;;=4^V76.11
 ;;^UTILITY(U,$J,358.3,2868,2)
 ;;=^317969
 ;;^UTILITY(U,$J,358.3,2869,0)
 ;;=V76.12^^28^249^70
 ;;^UTILITY(U,$J,358.3,2869,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2869,1,3,0)
 ;;=3^SCRN MAL NEOP MAMMO
 ;;^UTILITY(U,$J,358.3,2869,1,4,0)
 ;;=4^V76.12
 ;;^UTILITY(U,$J,358.3,2869,2)
 ;;=^317970
 ;;^UTILITY(U,$J,358.3,2870,0)
 ;;=V76.2^^28^249^67
 ;;^UTILITY(U,$J,358.3,2870,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2870,1,3,0)
 ;;=3^SCRN MAL NEOP CERVIX
 ;;^UTILITY(U,$J,358.3,2870,1,4,0)
 ;;=4^V76.2
 ;;^UTILITY(U,$J,358.3,2870,2)
 ;;=^295653
 ;;^UTILITY(U,$J,358.3,2871,0)
 ;;=V76.3^^28^249^65
 ;;^UTILITY(U,$J,358.3,2871,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2871,1,3,0)
 ;;=3^SCRN MAL NEOP BLADDER
 ;;^UTILITY(U,$J,358.3,2871,1,4,0)
 ;;=4^V76.3
 ;;^UTILITY(U,$J,358.3,2871,2)
 ;;=^295654
 ;;^UTILITY(U,$J,358.3,2872,0)
 ;;=V76.41^^28^249^76
 ;;^UTILITY(U,$J,358.3,2872,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2872,1,3,0)
 ;;=3^SCRN MAL NEOP RECTUM
 ;;^UTILITY(U,$J,358.3,2872,1,4,0)
 ;;=4^V76.41
 ;;^UTILITY(U,$J,358.3,2872,2)
 ;;=^295655
 ;;^UTILITY(U,$J,358.3,2873,0)
 ;;=V76.42^^28^249^73
 ;;^UTILITY(U,$J,358.3,2873,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2873,1,3,0)
 ;;=3^SCRN MAL NEOP ORAL CAV
 ;;^UTILITY(U,$J,358.3,2873,1,4,0)
 ;;=4^V76.42
 ;;^UTILITY(U,$J,358.3,2873,2)
 ;;=^295656
 ;;^UTILITY(U,$J,358.3,2874,0)
 ;;=V76.43^^28^249^78
 ;;^UTILITY(U,$J,358.3,2874,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2874,1,3,0)
 ;;=3^SCRN MAL NEOP SKIN
 ;;^UTILITY(U,$J,358.3,2874,1,4,0)
 ;;=4^V76.43
 ;;^UTILITY(U,$J,358.3,2874,2)
 ;;=^295657
 ;;^UTILITY(U,$J,358.3,2875,0)
 ;;=V76.44^^28^249^75
